Cargando…

Psychometric parameters of food allergy quality of life during an allergen immunotherapy trial

BACKGROUND: The Food Allergy Quality of Life Questionnaire–Parent Form (FAQLQ‐PF) is a commonly used patient‐reported outcome measure in food allergy (FA) research. It was developed before FA treatment clinical trials were commonplace and is used as a secondary outcome measure in pivotal FA treatmen...

Descripción completa

Detalles Bibliográficos
Autores principales: Lins de Holanda Coelho, Gabriel, DunnGalvin, Audrey, Greenhawt, Matthew, Hourihane, Jonathan O'B, Fleischer, David M., Chen, Gang, Shaker, Marcus, Campbell, Dianne E., Green, Todd D., Bégin, Philippe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9546060/
https://www.ncbi.nlm.nih.gov/pubmed/35466405
http://dx.doi.org/10.1111/all.15323
_version_ 1784804958176018432
author Lins de Holanda Coelho, Gabriel
DunnGalvin, Audrey
Greenhawt, Matthew
Hourihane, Jonathan O'B
Fleischer, David M.
Chen, Gang
Shaker, Marcus
Campbell, Dianne E.
Green, Todd D.
Bégin, Philippe
author_facet Lins de Holanda Coelho, Gabriel
DunnGalvin, Audrey
Greenhawt, Matthew
Hourihane, Jonathan O'B
Fleischer, David M.
Chen, Gang
Shaker, Marcus
Campbell, Dianne E.
Green, Todd D.
Bégin, Philippe
author_sort Lins de Holanda Coelho, Gabriel
collection PubMed
description BACKGROUND: The Food Allergy Quality of Life Questionnaire–Parent Form (FAQLQ‐PF) is a commonly used patient‐reported outcome measure in food allergy (FA) research. It was developed before FA treatment clinical trials were commonplace and is used as a secondary outcome measure in pivotal FA treatment trials. We examined the psychometric properties of the FAQLQ‐PF and its relevance to children with peanut allergy engaged in an epicutaneous immunotherapy (EPIT) clinical trial. METHODS: Analysis was performed on 26 universally answered items of the FAQLQ‐PF, from assessments undertaken during the phase 3 PEPITES study (baseline, Month 12), which examined the safety and efficacy of EPIT for children with peanut allergy aged 4–11 years. Item response theory (IRT) was used to assess psychometric parameters of the FAQLQ‐PF (i.e., discrimination, difficulty, and information). Confirmatory factor analysis was also employed; reliability was assessed using McDonald's omega (ω) and Cronbach's alpha (α). RESULTS: A total of 23 of 26 items presented very high discrimination levels (>1.7), and all 26 fell within the recommended difficulty threshold (between −1.5 and 1.5). The items contributed a reasonable information level for their respective factors/subdomains. The measure also presented a marginally acceptable model fit for the 3‐factor structure (e.g., comparative fit index = 0.88, Tucker–Lewis index = 0.87) and good reliability levels across time points (ω and α > 0.90). CONCLUSIONS: Herein, we present a novel reanalysis of the FAQLQ‐PF items using IRT. The longitudinal performance of individual items and subscales was corroborated, and items with the highest discrimination were identified, showing that the tool is suitable for longitudinal measurements in FA treatment trials.
format Online
Article
Text
id pubmed-9546060
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-95460602022-10-14 Psychometric parameters of food allergy quality of life during an allergen immunotherapy trial Lins de Holanda Coelho, Gabriel DunnGalvin, Audrey Greenhawt, Matthew Hourihane, Jonathan O'B Fleischer, David M. Chen, Gang Shaker, Marcus Campbell, Dianne E. Green, Todd D. Bégin, Philippe Allergy ORIGINAL ARTICLES BACKGROUND: The Food Allergy Quality of Life Questionnaire–Parent Form (FAQLQ‐PF) is a commonly used patient‐reported outcome measure in food allergy (FA) research. It was developed before FA treatment clinical trials were commonplace and is used as a secondary outcome measure in pivotal FA treatment trials. We examined the psychometric properties of the FAQLQ‐PF and its relevance to children with peanut allergy engaged in an epicutaneous immunotherapy (EPIT) clinical trial. METHODS: Analysis was performed on 26 universally answered items of the FAQLQ‐PF, from assessments undertaken during the phase 3 PEPITES study (baseline, Month 12), which examined the safety and efficacy of EPIT for children with peanut allergy aged 4–11 years. Item response theory (IRT) was used to assess psychometric parameters of the FAQLQ‐PF (i.e., discrimination, difficulty, and information). Confirmatory factor analysis was also employed; reliability was assessed using McDonald's omega (ω) and Cronbach's alpha (α). RESULTS: A total of 23 of 26 items presented very high discrimination levels (>1.7), and all 26 fell within the recommended difficulty threshold (between −1.5 and 1.5). The items contributed a reasonable information level for their respective factors/subdomains. The measure also presented a marginally acceptable model fit for the 3‐factor structure (e.g., comparative fit index = 0.88, Tucker–Lewis index = 0.87) and good reliability levels across time points (ω and α > 0.90). CONCLUSIONS: Herein, we present a novel reanalysis of the FAQLQ‐PF items using IRT. The longitudinal performance of individual items and subscales was corroborated, and items with the highest discrimination were identified, showing that the tool is suitable for longitudinal measurements in FA treatment trials. John Wiley and Sons Inc. 2022-05-02 2022-09 /pmc/articles/PMC9546060/ /pubmed/35466405 http://dx.doi.org/10.1111/all.15323 Text en © 2022 The Authors. Allergy published by European Academy of Allergy and Clinical Immunology and John Wiley & Sons Ltd. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.
spellingShingle ORIGINAL ARTICLES
Lins de Holanda Coelho, Gabriel
DunnGalvin, Audrey
Greenhawt, Matthew
Hourihane, Jonathan O'B
Fleischer, David M.
Chen, Gang
Shaker, Marcus
Campbell, Dianne E.
Green, Todd D.
Bégin, Philippe
Psychometric parameters of food allergy quality of life during an allergen immunotherapy trial
title Psychometric parameters of food allergy quality of life during an allergen immunotherapy trial
title_full Psychometric parameters of food allergy quality of life during an allergen immunotherapy trial
title_fullStr Psychometric parameters of food allergy quality of life during an allergen immunotherapy trial
title_full_unstemmed Psychometric parameters of food allergy quality of life during an allergen immunotherapy trial
title_short Psychometric parameters of food allergy quality of life during an allergen immunotherapy trial
title_sort psychometric parameters of food allergy quality of life during an allergen immunotherapy trial
topic ORIGINAL ARTICLES
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9546060/
https://www.ncbi.nlm.nih.gov/pubmed/35466405
http://dx.doi.org/10.1111/all.15323
work_keys_str_mv AT linsdeholandacoelhogabriel psychometricparametersoffoodallergyqualityoflifeduringanallergenimmunotherapytrial
AT dunngalvinaudrey psychometricparametersoffoodallergyqualityoflifeduringanallergenimmunotherapytrial
AT greenhawtmatthew psychometricparametersoffoodallergyqualityoflifeduringanallergenimmunotherapytrial
AT hourihanejonathanob psychometricparametersoffoodallergyqualityoflifeduringanallergenimmunotherapytrial
AT fleischerdavidm psychometricparametersoffoodallergyqualityoflifeduringanallergenimmunotherapytrial
AT chengang psychometricparametersoffoodallergyqualityoflifeduringanallergenimmunotherapytrial
AT shakermarcus psychometricparametersoffoodallergyqualityoflifeduringanallergenimmunotherapytrial
AT campbelldiannee psychometricparametersoffoodallergyqualityoflifeduringanallergenimmunotherapytrial
AT greentoddd psychometricparametersoffoodallergyqualityoflifeduringanallergenimmunotherapytrial
AT beginphilippe psychometricparametersoffoodallergyqualityoflifeduringanallergenimmunotherapytrial